Interleukin-1 blockade with RPH-104 in patients with acute ST-elevation myocardial infarction: study design and rationale
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-1 blockade with RPH-104 in patients with acute ST-elevation myocardial infarction: study design and rationale
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-26
DOI
10.1186/s12967-021-02828-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
- (2020) Salim S. Virani et al. CIRCULATION
- Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction
- (2020) Antonio Abbate et al. Journal of the American Heart Association
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
- (2020) Antonio Abbate et al. CIRCULATION RESEARCH
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
- (2019) Emelia J. Benjamin et al. CIRCULATION
- Structural Basis of IL-1 Family Cytokine Signaling
- (2019) James K. Fields et al. Frontiers in Immunology
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
- (2018) Karen A. Hicks et al. CIRCULATION
- C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up
- (2018) Maarten Vanhaverbeke et al. CLINICAL CARDIOLOGY
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin 1α and the inflammatory process
- (2016) Nelson C Di Paolo et al. NATURE IMMUNOLOGY
- Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study
- (2015) K. Dharmarajan et al. BMJ-British Medical Journal
- Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study
- (2015) K. Dharmarajan et al. BMJ-British Medical Journal
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
- (2013) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- National Trends in Heart Failure Hospitalization After Acute Myocardial Infarction for Medicare Beneficiaries
- (2013) Jersey Chen et al. CIRCULATION
- Targeting Interleukin-1 in Heart Disease
- (2013) Benjamin W. Van Tassell et al. CIRCULATION
- Epidemiology of Heart Failure
- (2013) Véronique L. Roger CIRCULATION RESEARCH
- The annual global economic burden of heart failure
- (2013) Christopher Cook et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
- (2011) E. Mezzaroma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI
- (2010) F. Roubille et al. European Journal of Internal Medicine
- Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction
- (2008) Antonio Abbate et al. CIRCULATION
- Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction
- (2008) Raghava S. Velagaleti et al. CIRCULATION
- Concentrations of C-Reactive Protein and B-Type Natriuretic Peptide 30 Days after Acute Coronary Syndromes Independently Predict Hospitalization for Heart Failure and Cardiovascular Death
- (2008) B. M. Scirica et al. CLINICAL CHEMISTRY
- The immune system and cardiac repair
- (2008) N FRANGOGIANNIS PHARMACOLOGICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started